Sub-Total: $0.00
Boss∣∣Reta30 SLPR Retatrutide 30MG
$168.00
Retatrutide is a multi-receptor agonist peptide being studied for its potential to address obesity and type 2 diabetes. It mimics multiple incretin pathways, potentially enhancing insulin secretion, reducing appetite, and improving energy balance. As it targets multiple receptors, it’s being investigated for comprehensive metabolic benefits. BOSS Peptide offers high-purity.
Description
Retatrutide is a “triple agonist” peptide (GLP-1, GIP, and glucagon receptor agonist) designed for treating obesity. Superior weight loss up to 24-29% body weight along with enhanced fat burning, muscle preservation, improved metabolic health (blood sugar/insulin), lower blood pressure, and potential reversal of fatty liver disease. Triple-Action Mechanism: Unlike dual (GLP-1/GIP) or single (GLP-1) agonists, retatrutide targets three receptors to suppress appetite, boost fat burning, and slow digestion for improved satiety.
Fat Reduction: Targets and reduces harmful visceral fat.
Liver Health: Reduces fatty liver buildup (MASLD).
Cardiovascular Health: Improves cholesterol levels and lowers blood pressure.
Muscle Preservation: it preserves lean body mass better than previous generations of weight loss medication.
Reduced Food Noise: significantly lower cravings and better control over eating habits
Retatrutide peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering.
